Ohsu Knight Cancer Institute
Clinical trials sponsored by Ohsu Knight Cancer Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan may find hidden prostate cancer when standard test fails Results expected Dec 2026 (estimated)
- New combo therapy targets tough lymphoma in early trial Results expected Dec 2026 (estimated)
- Oregon launches massive melanoma awareness push – 75,000 people enrolled Results expected Dec 2026 (estimated)
- No-Scope cancer screening could save lives in rural oregon Results expected Dec 2026 (estimated)
- Fiber supplements may alter gut bacteria linked to colon cancer risk Results expected Dec 2026 (estimated)
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The treatment combines a type of internal radiation (Y-90) with two immunotherapy drugs (durvalumab and tremelimumab) and a targeted therapy pill (zanzalintinib). The goal is…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Pancreas removal plus islet transplant: a new option for benign tumors?
Disease control Not yet recruitingThis early-phase study tests a surgery that removes the entire pancreas and then transplants the patient's own insulin-making cells into the liver. The goal is to treat chronic pancreatitis and benign tumors while reducing the risk of diabetes. The study includes 12 adults with a…
Phase 1/2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a buddy system help head and neck cancer patients? new study aims to find out
Symptom relief Not yet recruitingThis trial tests whether a one-on-one peer support program is feasible for people with head and neck cancer. Patients (mentees) are matched with cancer survivors (mentors) for emotional and informational support. The study will enroll 56 participants and measure how many actually…
Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can a smartphone app help melanoma patients avoid severe side effects from immunotherapy?
Symptom relief Not yet recruitingThis study tests whether having melanoma patients regularly report their symptoms through an electronic tool, combined with quick access to specialist care, can improve the management of side effects from immune checkpoint inhibitors. These drugs can cause immune-related side eff…
Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Online strength training tested to keep older cancer survivors moving
Symptom relief Not yet recruitingThis study tests whether live, online group strength training can help older cancer survivors (age 65+) who have trouble with daily activities. 150 participants will be split into three groups: immediate strength training, delayed strength training, or stretching. The goal is to …
Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC